Factors determining the potential for onward transmission of variant Creutzfeldt-Jakob disease via surgical instruments

Journal of the Royal Society Interface

Volumn 3, Issue 11, 2006, Pages 757-766

  Garske, Tini ^a   Ward, Hester J T ^b   Clarke, Paul ^a   Will, Robert G ^b   Ghani, Azra C ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Mathematical model; Self sustaining epidemic; Variant Creutzfeldt Jakob disease

Indexed keywords

PRION PROTEIN;

AGE DISTRIBUTION; BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; EPIDEMIC; HUMAN; PROTEIN LOCALIZATION; REVIEW; RISK FACTOR; SURGICAL INSTRUMENT; UNITED KINGDOM;

EID: 33845437683     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2006.0142     Document Type: Review

References (26)

1. Anderson, R. M. & May, R. M. 1991 Infectious diseases of humans. Oxford, UK: Oxford University Press.
2. Bishop, M. T. et al. 2006 Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 5, 393-398. (doi:10.1016/S1474-4422(06)70413-6)
3. Bruce, M. E. et al. 1997 Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501. (doi:10.1038/39057)
4. Clarke, P. & Ghani, A. C. 2005 Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility. J. R. Soc. Interface 2, 9-31. (doi:10.1098/rsif.2004.0017)
5. Clarke, P., Will, R. G. & Ghani, A. C. Submitted. Is there the potential for a self-sustaining epidemic of variant creutzfeldt-jakob disease via blood transfusion in the UK?
6. 0 in models for infectious diseases in heterogeneous populations. J. Math. Biol. 28, 365-382. (doi:10.1007/BF00178324)
7. Donnelly, C. A., Ferguson, N. M., Ghani, A. C. & Anderson, R. M. 2002 Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels. Proc. R. Soc. B 269, 2179-2190. (doi:10.1098/rspb.2002.2156)
8. Economics and Operational Research Division 2001 Risk assessment for transmission of vCJD via surgical instruments: a modelling approach and numerical scenarios. Technical report, Department of Health.
9. Flechsig, E., Hegyi, I., Enari, M., Schwarz, P., Collinge, J. & Weissmann, C. 2001 Transmission of scrapie by steel-surface-bound prions. Mol. Med. 7, 679-684.
10. Ghani, A. C., Donnelly, C. A., Ferguson, N. M. & Anderson, R. M. 2003 Updated projections of future vCJD deaths in the UK. BMC Infect. Dis., 30.
11. Hill, A. F. & Collinge, J. 2003 Subclinical prion infection. Trends Microbiol. 11, 578-584. (doi:10.1016/j.tim.2003.10.007)
12. Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. C. L., Gowland, I., Collinge, J., Doey, L. J. & Lantos, P. 1997 The same prion strain causes vCJD and BSE. Nature 389, 448-450. (doi:10.1038/38925)
13. Hill, A. F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P. L. & Collinge, J. 2000 Species-barrier-independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 97, 10 248-10 253. (doi:10.1073/pnas.97.18.10248)
14. Hilton, D. A., Fathers, E., Edwards, P., Ironside, J. W. & Zajicek, J. 1998 Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. The Lancet 352, 703-704. (doi:10.1016/S0140-6736(98) 24035-9)
15. Hilton, D. A., Ghani, A. C., Conyers, L., Edwards, P., McCardle, L., Ritchie, D., Penney, M., Hegazy, D. & Ironside, J. W. 2004 Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 203, 733-739. (doi:10.1002/path.1580)
16. HSMO 1990 Tabular list of the classification of surgical operations and procedures, vol. 1. TSO.
17. Jackson, G. S. et al. 2005 An enzyme-detergent method for effective prion decontamination of surgical steel. J. Gen. Virol. 86, 869-878. (doi:10.1099/vir.0.80484-0)
18. NHS Estates 2000 Decontamination review: report on a survey of current decontamination practices in healthcare premises in England. Technical report, Department of Health.
19. NHS Estates 2001 A review of the decontamination of surgical instruments in the NHS in England. Technical report, Department of Health.
20. Peden, A. H., Head, M. W., Ritchie, D. L., Bell, J. E. & Ironside, J. W. 2004 Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529. (doi:10.1016/S0140-6736(04)16811-6)
21. Scott, M. R., Will, R., Ironside, J. Nguyen, H.-O. B., Tremblay, P., DeArmond, S. J. & Prusiner, S. B. 1999 Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc. Natl Acad. Sci. USA 96, 15 137-15 142. (doi:10.1073/pnas.96.26.15137)
22. Wadsworth, J. D., Joiner, S., Hill, A. P., Campbell, T. A., Desbruslais, M., Luthert, P. J. & Collinge, J. 2001 Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358, 171-180. (doi:10.1016/S0140-6736(01) 05403-4)
23. Ward, H. J. T. et al. 2006 Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann. Neurol. 59, 111-120. (doi:10.1002/ana.20708)
24. Wells, A. W., Mounter, P. J., Chapman, C. E., Stainsby, D. & Wallis, J. P. 2002 Where does blood go? Prospective observational study of red cell transfusion in north England. Br. Med. J. 325, 803.
25. WHO 2003 WHO guidelines on transmissible spongiform encephalopathies in relation to biological and pharmaceutical products. Technical report, WHO, Geneva.
26. Yan, Z., Stitz, L., Heeg, P., Pfaff, E. & Roth, K. 2004 Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect. Control Hosp. Epidemiol. 25, 280-283. (doi:10.1086/502392)